iCAD Inc (iCAD) is a medical technology company that provides AI-powered cancer detection technologies. The company develops and markets solutions for cancer detection and risk assessment. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. Its major product is the ProFound Breast Health Suite, which includes solutions for breast cancer detection, density assessment, and cardiovascular risk evaluation. The company uses artificial intelligence for its product development. iCAD operates in the US and markets products through direct sales organization, OEM partners, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company iCAD Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- iCAD Inc Company Overview
- iCAD Inc Company Snapshot
- iCAD Inc Pipeline Products and Ongoing Clinical Trials Overview
- iCAD Inc - Pipeline Analysis Overview
- Business Description
- iCAD Inc - Key Facts
- iCAD Inc - Major Products and Services
- iCAD Inc Pipeline Products by Development Stage
- iCAD Inc Pipeline Products Overview
- AI - Cardiovascular Risk Detection
- AI - Cardiovascular Risk Detection Product Overview
- Artificial Intelligence-Based System - Breast Cancer Risk Prediction
- Artificial Intelligence-Based System - Breast Cancer Risk Prediction Product Overview
- Integrated Profound AI - 2D Mammography
- Integrated Profound AI - 2D Mammography Product Overview
- Integrated Profound AI - 3D Mammography
- Integrated Profound AI - 3D Mammography Product Overview
- M-Vu CAD System - Tomosynthesis
- M-Vu CAD System - Tomosynthesis Product Overview
- MRI-Guided Prostate Biopsy
- MRI-Guided Prostate Biopsy Product Overview
- ProFound AI Suite
- ProFound AI Suite Product Overview
- Prostate MR/TRUS-Fusion Device
- Prostate MR/TRUS-Fusion Device Product Overview
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer Product Overview
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer Product Overview
- Xoft Brain IORT System
- Xoft Brain IORT System Product Overview
- iCAD Inc - Key Competitors
- iCAD Inc - Key Employees
- iCAD Inc - Key Employee Biographies
- iCAD Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- iCAD Inc, Recent Developments
- Oct 03, 2024: iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
- Jul 29, 2024: iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
- Jun 26, 2024: iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
- Apr 09, 2024: iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
- Apr 02, 2024: iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
- Aug 16, 2023: Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
- Aug 14, 2023: iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader
- Jul 18, 2023: iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
- Jul 10, 2023: iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
- May 18, 2023: iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- iCAD Inc Pipeline Products and Ongoing Clinical Trials Overview
- iCAD Inc Pipeline Products by Equipment Type
- iCAD Inc Pipeline Products by Indication
- iCAD Inc, Key Facts
- iCAD Inc, Major Products and Services
- iCAD Inc Number of Pipeline Products by Development Stage
- iCAD Inc Pipeline Products Summary by Development Stage
- AI - Cardiovascular Risk Detection - Product Status
- AI - Cardiovascular Risk Detection - Product Description
- Artificial Intelligence-Based System - Breast Cancer Risk Prediction - Product Status
- Artificial Intelligence-Based System - Breast Cancer Risk Prediction - Product Description
- Integrated Profound AI - 2D Mammography - Product Status
- Integrated Profound AI - 2D Mammography - Product Description
- Integrated Profound AI - 3D Mammography - Product Status
- Integrated Profound AI - 3D Mammography - Product Description
- M-Vu CAD System - Tomosynthesis - Product Status
- M-Vu CAD System - Tomosynthesis - Product Description
- MRI-Guided Prostate Biopsy - Product Status
- MRI-Guided Prostate Biopsy - Product Description
- ProFound AI Suite - Product Status
- ProFound AI Suite - Product Description
- Prostate MR/TRUS-Fusion Device - Product Status
- Prostate MR/TRUS-Fusion Device - Product Description
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Status
- Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer - Product Description
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Status
- Xoft Axxent Electronic Brachytherapy System - Prostate Cancer - Product Description
- Xoft Brain IORT System - Product Status
- Xoft Brain IORT System - Product Description
- iCAD Inc, Key Employees
- iCAD Inc, Key Employee Biographies
- iCAD Inc, Other Locations
- iCAD Inc, Subsidiaries
- Glossary
- iCAD Inc Pipeline Products by Equipment Type
- iCAD Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sensus Healthcare Inc
- Densitas Inc.
- Siemens Medical Solutions USA Inc
- Philips Healthcare Informatics Inc
- Hologic Inc
- ScreenPoint Medical BV
- GE HealthCare Technologies Inc
- Volpara Health Technologies Ltd
- Carl Zeiss Meditec AG
- Intraop Medical Corporation
- Elekta Inc
